Orphan drug designation – Europe, the USA and Japan
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Link
http://www.tandfonline.com/doi/pdf/10.1517/21678707.2013.769876
Reference6 articles.
1. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: Towards a made-in-China orphan drug policy
2. Orphan drugs: the regulatory environment
3. Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency
4. Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years
5. European regulation on orphan medicinal products: 10 years of experience and future perspectives
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gaucher Disease: A Glance from a Medicinal Chemistry Perspective;ChemMedChem;2024-03-08
2. Öksüz İlaçlar ve Öksüz İlaçların Yeni İlaç Geliştirilmesindeki Yeri;Hacettepe University Journal of the Faculty of Pharmacy;2022-12-25
3. Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?;Orphanet Journal of Rare Diseases;2022-04-05
4. Orphan Drugs;ELSEVIER ESSENTIALS Seltene Erkrankungen in der Inneren Medizin;2021
5. Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network;Orphanet Journal of Rare Diseases;2020-01-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3